Neuromusculaire Monitoring Survey

Survey, Financial Clinical Trial

Official title:

Neuromusculaire Monitoring Survey - Financial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04564404
• Other study ID #: EUNeuroMuscMonitoringSurvey2
• Status: Completed
• Phase: N/A
• Start date: November 10, 2021
• Est. completion date: March 10, 2022

Study information

• Verified date: September 2021
• Source: Universitair Ziekenhuis Brussel
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This survey aims to better define the willingness-to-buy for Applications in Neuromuscular Monitoring throughout European hospitals.

Description:

This study consists of a simple online survey that takes approximately 2 minutes to complete.

The study aims to assess the willingness-to-buy for Applications in Neuromuscular Monitoring (monitoring and software-based) within the anesthesia departments of European hospitals. The survey is targeted to the department heads of the questioned anesthesia departments.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 692
• Est. completion date: March 10, 2022
• Est. primary completion date: March 10, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Active Anesthesiology department heads of European Anesthesiology departments.

Exclusion Criteria:

• None

Related Conditions & MeSH terms

• Survey, Financial

Intervention

Other:
• Survey
Questionnaire to ask about the willingness-to-buy applications in neuromuscular monitoring.

Locations

Country	Name	City	State
Belgium	UZ Brussel	Jette	Brussel

Sponsors (1)

Lead Sponsor	Collaborator
Universitair Ziekenhuis Brussel

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Willingness to buy questionnaire	Would this person be willing to buy neuromuscular monitoring applications.	4 months